Table 2.
Reference | Age and Gender | Pre-Operative Visual Acuity | Post-Operative Visual Acuity | Dosage of Cyclosporin a | Follow-Up Time | Clinical Outcome | Further Information |
---|---|---|---|---|---|---|---|
[26] | 32, female | PL | PL | 3.5 mg/kg for 6 months | 6 months | failure | |
[27] | 3, female | unknown | 20/160, amblyopia | nil | 27 months | success | DNA from host only at months 1 and 6 |
[27] | 31, female | 4/200 | 4/200 | 3 mg/kg tapered to 2 mg/kg after 2 weeks, indefinitely | 27 months | failure | DNA from host only at month 7 |
VA: visual acuity; PL: perception of light.